Maravai LifeSciences Holdings, Inc. - Class A common stock (MRVI) Covered Calls

You can sell covered calls on Maravai LifeSciences Holdings, Inc. - Class A common stock to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for MRVI (prices last updated Fri 4:16 PM ET):

Maravai LifeSciences Holdings, Inc. - Class A common stock (MRVI) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
8.97 +0.17 8.16 9.39 1.8M - 2.3
Covered Calls For Maravai LifeSciences Holdings, Inc. - Class A common stock (MRVI)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
May 17 10 0.10 9.29 1.1% 26.8%
Jun 21 10 0.00 9.39 0.0% 0.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Maravai LifeSciences Holdings, Inc. operates as a life sciences company that provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in three segments: Nucleic Acid Production, Biologics Safety Testing, and Protein Detection. The Nucleic Acid Production segment manufactures and sells products used in the fields of gene therapy, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody and assay development services. The Protein Detection segment sells labeling and detection reagents for researchers in immunohistochemistry. The company serves biopharmaceutical companies, and other emerging biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. Maravai LifeSciences Holdings, Inc. was incorporated in 2020 and is headquartered in San Diego, California.